StockData
MediWound Ltd. logo

MediWound Ltd. (MDWD) stock

MDWDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$13.59+0.05 (+0.37%)

Close on Nov 20, 2026Market cap $174.43MP/E –Yield –

MediWound gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2025 it was $3.25M, up 23.5% from the year before. The highest annual figure on record is $19.94M in fiscal 2019.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.25M+23.5%
FY2024Dec 31, 2024$2.63M-26.4%
FY2023Dec 31, 2023$3.58M-72.8%
FY2022Dec 31, 2022$13.17M+50.1%
FY2021Dec 31, 2021$8.77M+16.2%
FY2020Dec 31, 2020$7.55M-62.2%
FY2019Dec 31, 2019$19.94M+1418.7%
FY2018Dec 31, 2018$1.31M+43.0%
FY2017Dec 31, 2017$918.00K–
FY2016Dec 31, 2016-$600.00K–
FY2015Dec 31, 2015-$1.92M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$337.00K-69.7%
Q2 FY2025Jun 30, 2025$1.34M-43.2%
Q2 FY2024Jun 30, 2024$447.00K-63.3%
Q2 FY2023Jun 30, 2023$1.14M-93.4%
Q2 FY2022Jun 30, 2022$1.11M+176.9%
Q2 FY2021Jun 30, 2021$2.36M+1063.1%
Q2 FY2020Jun 30, 2020$1.22M–
Q2 FY2019Jun 30, 2019$17.27M–
Q2 FY2018Jun 30, 2018$402.00K–
Q2 FY2017Jun 30, 2017$203.00K–

More MediWound figures

See a number that looks wrong?